Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.51 |
| ▸ | SELL | P14151 | 1/20 | 0.46 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
| ▸ | SIGLEC7 | Q9Y286 | 5/20 | 0.44 |
| ▸ | CD22 | P20273 | 2/20 | 0.44 |
| ▸ | MAG | P20916 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1204652 | 0.91 | NANP (0.56) | NANPSELLSELPSIGLEC7CD22 | |
| SCHEMBL6124964 | 0.86 | L3MBTL1 (0.39) | NANPSELLSELPSIGLEC7CD22 | |
| SCHEMBL17300145 | 0.83 | NANP (0.60) | NANPSELLSELPSIGLEC7CD22 | |
| SCHEMBL29226229 | 0.83 | NANP (0.60) | NANPSELLSELPSIGLEC7CD22 | |
| SCHEMBL18357290 | 0.82 | NANP (0.58) | NANPSELLSELPSIGLEC7CD22 | |
| SCHEMBL16839997 | 0.82 | NANP (0.58) | NANPSELLSELPSIGLEC7CD22 | |
| SCHEMBL15087687 | 0.82 | NANP (0.58) | NANPSELLSELPSIGLEC7CD22 | |
| SCHEMBL18083879 | 0.81 | CD22 (0.56) | NANPSELLSELPSIGLEC7CD22 | |
| SCHEMBL15090247 | 0.81 | CD22 (0.56) | NANPSELLSELPSIGLEC7CD22 | |
| SCHEMBL17715151 | 0.81 | CD22 (0.56) | NANPSELLSELPSIGLEC7CD22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120121511-A1 | INFECTION DETECTION METHODS AND SYSTEMS AND RELATED COMPOUNDS AND COMPOSITIONS | LOS ALAMOS NATIONAL SECURITY, LLC | 2012-05-17 | — | — | US | disclosed |
| US-20120122079-A1 | INFECTION DETECTION METHODS AND SYSTEMS AND RELATED COMPOUNDS AND COMPOSITIONS | LOS ALAMOS NATIONAL SECURITY, LLC | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120121511-A1 | INFECTION DETECTION METHODS AND SYSTEMS AND RELATED COMPOUNDS AND COMPOSITIONS | SI, GLA, ENGASE | NANP 254/4885SELL 1211/4885SELP 1153/4885 |
| US-20120122079-A1 | INFECTION DETECTION METHODS AND SYSTEMS AND RELATED COMPOUNDS AND COMPOSITIONS | SI, CA14, CA4 | NANP 403/4885SELL 3382/4885SELP 3329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.